Mazindol

马吲哚

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMazindol
Drug Alias Name马引朵氯苯咪吲哚吗吲哚美新达Sanorex +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporterDopamine transporter
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityCocaine-Related DisordersObesity +[5] 
Global Approved IndicationsObesity
Approved Indications in ChinaObesity
Original Approved Country/TerritoryUnited States
Original Approved Date1973/06/14
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNls PharmaJiangsu Disainuo Pharmaceutical Co Ltd
Inactive CompaniesYale UniversityNovartis Pharma Ag
Active IndicationsObesityCataplexyNarcolepsy
Inactive IndicationsAttention Deficit Disorder with HyperactivityCocaine-Related Disorders

Other Information

ATC CodeA08AA05
Related LinksWikipediaDrugBankKEGG